Meta-Analysis: Studies Usually Show DTx To Be Often Cost-Effective, Although Methodology Differs
August 10th 2023In two-thirds of published studies, digital therapeutics were found to be cost-effective, and they led to cost savings in most of the other studies. However, most of the research was funded by industry and that might limit its impact.
Read More
CAR T Cells Could Change the Face of Autoimmune Therapy | Research Review
June 28th 2023Manipulating T cells to target cancer cells has worked to treat some cancers. Researchers are investigating whether the same approach might be used to curb the dysregulated immune response that underlies autoimmune disease.
Read More
Under Attack: Has Ransomware Become Just Another Cost of Doing Business in Healthcare?
May 17th 2023There are many reasons the ransomware problem has been hard to stop. One reason is that ransomware is good business. A 2021 U.S. Treasury Department identified more than $5 billion worth of outgoing bitcoin cryptocurrency payments it suspects may have been related to ransomware attacks.
Read More